Elena Elez Fernandez (Elena Elez, E Elez, Elena Élez)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 29

Top Venues

Nature medicine

Nature communications

Journal for immunotherapy of cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Vall d´Hebron Institut d´Oncologia

Universidad Autónoma de Barcelona (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vall d´Hebron Institut d´Oncologia Jan 01 2007

Spain

Attending Physician :: Oncology Service

Education History

Universidad Autónoma de Barcelona Jul 10 2015

Spain

PHD :: medicine and surgery

Publications

Akihito Kawazoe, Rui-Hua Xu, Pilar García Alfonso, Maria Passhak, Hao-Wei Teng, Ardaman Shergill, Mahmut Gümüş, Camilla Qvortrup, Sebastian Stinzing, Kathryn Towns, Tae Won Kim, Kai-Keen Shiu, Juan Cundom, Sumitra Ananda, Andrey Lebedinets, Rong Fu, Rishi Jain, David Adelberg, Volker Heinemann, Takayuki Yoshino, Elena Elez Fernandez, null null
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Akihito Kawazoe, Rui-Hua Xu, Pilar García Alfonso, Maria Passhak, Hao-Wei Teng, Ardaman Shergill, Mahmut Gümüş, Camilla Qvortrup, Sebastian Stinzing, Kathryn Towns, Tae Won Kim, Kai-Keen Shiu, Juan Cundom, Sumitra Ananda, Andrey Lebedinets, Rong Fu, Rishi Jain, David Adelberg, Volker Heinemann, Takayuki Yoshino, Elena Elez Fernandez, null null
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Akihito Kawazoe, Rui-Hua Xu, Pilar García Alfonso, Maria Passhak, Hao-Wei Teng, Ardaman Shergill, Mahmut Gümüş, Camilla Qvortrup, Sebastian Stinzing, Kathryn Towns, Tae Won Kim, Kai-Keen Shiu, Juan Cundom, Sumitra Ananda, Andrey Lebedinets, Rong Fu, Rishi Jain, David Adelberg, Volker Heinemann, Takayuki Yoshino, Elena Elez Fernandez, null null
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Jordi Martínez-Quintanilla, Débora Cabot, Doménico Sabia, Oriol Arqués, Jordi Vergés, Irene Chicote, Lana Bijelic, Laia Cabellos, Anna M Alcántara, Maria Isabel Ramos Bernadó, Pedro Barrios, Oriol Crusellas, Lina M Palacio, Juan-Antonio C Serrano, Jorge Barriuso, Juan J Jiménez, Pau M Muñoz-Torres, Lara Nonell, Raquel Flores, Enzo Medico, Marcello Guaglio, Javier Ros, Elena Elez Fernandez, Josep Tabernero, Omer Aziz, Marcello Deraco, Héctor G Palmer
Precision oncology and systemic targeted therapy in Pseudomyxoma Peritonei. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Heinz-Josef Lenz, Aparna Parikh, David R Spigel, Allen L Cohn, Takayuki Yoshino, Mark Kochenderfer, Elena Elez Fernandez, Spencer H Shao, Dustin Deming, Regan Holdridge, Timothy Larson, Eric X Chen, Amit Mahipal, Antonio Ucar, Dana Cullen, Edwina Baskin-Bey, Tong Kang, Amy B Hammell, Jin Yao, Josep Tabernero
Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial. Journal for immunotherapy of cancer 12 (3) (2024)
Heinz-Josef Lenz, Aparna Parikh, David R Spigel, Allen L Cohn, Takayuki Yoshino, Mark Kochenderfer, Elena Elez Fernandez, Spencer H Shao, Dustin Deming, Regan Holdridge, Timothy Larson, Eric X Chen, Amit Mahipal, Antonio Ucar, Dana Cullen, Edwina Baskin-Bey, Tong Kang, Amy B Hammell, Jin Yao, Josep Tabernero
Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial. Journal for immunotherapy of cancer 12 (3) (2024)
Heinz-Josef Lenz, Aparna Parikh, David R Spigel, Allen L Cohn, Takayuki Yoshino, Mark Kochenderfer, Elena Elez Fernandez, Spencer H Shao, Dustin Deming, Regan Holdridge, Timothy Larson, Eric X Chen, Amit Mahipal, Antonio Ucar, Dana Cullen, Edwina Baskin-Bey, Tong Kang, Amy B Hammell, Jin Yao, Josep Tabernero
Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial. Journal for immunotherapy of cancer 12 (3) (2024)
Heinz-Josef Lenz, Aparna Parikh, David R Spigel, Allen L Cohn, Takayuki Yoshino, Mark Kochenderfer, Elena Elez Fernandez, Spencer H Shao, Dustin Deming, Regan Holdridge, Timothy Larson, Eric X Chen, Amit Mahipal, Antonio Ucar, Dana Cullen, Edwina Baskin-Bey, Tong Kang, Amy B Hammell, Jin Yao, Josep Tabernero
Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial. Journal for immunotherapy of cancer 12 (3) (2024)
Akihito Kawazoe, Rui-Hua Xu, Pilar García Alfonso, Maria Passhak, Hao-Wei Teng, Ardaman Shergill, Mahmut Gümüş, Camilla Qvortrup, Sebastian Stinzing, Kathryn Towns, Tae Won Kim, Kai-Keen Shiu, Juan Cundom, Sumitra Ananda, Andrey Lebedinets, Rong Fu, Rishi Jain, David Adelberg, Volker Heinemann, Takayuki Yoshino, Elena Elez Fernandez, null null
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Heinz-Josef Lenz, Aparna Parikh, David R Spigel, Allen L Cohn, Takayuki Yoshino, Mark Kochenderfer, Elena Elez Fernandez, Spencer H Shao, Dustin Deming, Regan Holdridge, Timothy Larson, Eric X Chen, Amit Mahipal, Antonio Ucar, Dana Cullen, Edwina Baskin-Bey, Tong Kang, Amy B Hammell, Jin Yao, Josep Tabernero
Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial. Journal for immunotherapy of cancer 12 (3) (2024)
Neil H Segal, Jeanne Tie, Scott Kopetz, Michel Ducreux, Eric Chen, Rodrigo Dienstmann, Antoine Hollebecque, Matthew J Reilley, Elena Elez Fernandez, Jan Cosaert, Jason Cain, Yee Soo-Hoo, Nicola Hewson, Zachary A Cooper, Rakesh Kumar, Josep Tabernero
COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancer. British journal of cancer (2024)
Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, Alba Recort-Bascuas, Ana Méndez, Noemí Manero-Rupérez, Daniele Lo Re, Elisa I Rivas, Marc Guiu, Melissa Zwick, Mar Iglesias, Carolina Martinez-Ciarpaglini, Noelia Tarazona, Monica Varese, Xavier Hernando-Momblona, Adrià Cañellas-Socias, Mayra Orrillo, Marta Garrido, Nadia Saoudi, Elena Elez Fernandez, Pilar Navarro, Josep Tabernero, Roger R Gomis, Eduard Batlle, Jorge Pisonero, Andres Cervantes, Clara Montagut, Alexandre Calon
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy. Nature communications 14 (1) (2023)
Javier Ros, Francesc Salva, Cristina Dopazo, Daniel López, Nadia Saoudi, Iosune Baraibar, Ramon Charco, Josep Tabernero, Elena Elez Fernandez
Correction To: Liver transplantation in metastatic colorectal cancer: are we ready for it? British journal of cancer (2023)
Giovanni Randon, Yoshiaki Nakamura, Rona Yaeger, Sara Lonardi, Chiara Cremolini, Elena Elez Fernandez, Federico Nichetti, Filippo Ghelardi, Vincenzo Nasca, Francesca Bergamo, Veronica Conca, Javier Ros, Hideaki Bando, Giulia Maddalena, Simone Oldani, Michele Prisciandaro, Alessandra Raimondi, Alexa B Schrock, Luca Agnelli, Henry S Walch, Takayuki Yoshino, Filippo Pietrantonio
Negative hyper-selection of patients with HER2-positive and RAS wild-type metastatic colorectal cancer receiving dual HER2 blockade: the PRESSING-HER2 study. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Elena Elez Fernandez, Javier Ros, Josep Tabernero
Seeking therapeutic synergy in BRAF mutant colorectal cancer. Nature medicine 29 (2) (2023)
Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, Alba Recort-Bascuas, Ana Méndez, Noemí Manero-Rupérez, Daniele Lo Re, Elisa I Rivas, Marc Guiu, Melissa Zwick, Mar Iglesias, Carolina Martinez-Ciarpaglini, Noelia Tarazona, Monica Varese, Xavier Hernando-Momblona, Adrià Cañellas-Socias, Mayra Orrillo, Marta Garrido, Nadia Saoudi, Elena Elez Fernandez, Pilar Navarro, Josep Tabernero, Roger R Gomis, Eduard Batlle, Jorge Pisonero, Andres Cervantes, Clara Montagut, Alexandre Calon
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy. Nature communications 14 (1) (2023)
Takayuki Yoshino, Maria Di Bartolomeo, Kanwal P S Raghav, Toshiki Masuishi, Fotios Loupakis, Hiasto Kawakami, Kensei Yamaguchi, Tomohiro Nishina, Zev Wainberg, Elena Elez Fernandez, Javier Rodriguez, Marwan Fakih, Fortunato Ciardiello, Kapil Saxena, Kojiro Kobayashi, Emarjola Bako, Yasuyuki Okuda, Gerold Meinhardt, Axel Grothey, Salvatore Siena, null null
Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer. Nature communications 14 (1) (2023)
Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, Alba Recort-Bascuas, Ana Méndez, Noemí Manero-Rupérez, Daniele Lo Re, Elisa I Rivas, Marc Guiu, Melissa Zwick, Mar Iglesias, Carolina Martinez-Ciarpaglini, Noelia Tarazona, Monica Varese, Xavier Hernando-Momblona, Adrià Cañellas-Socias, Mayra Orrillo, Marta Garrido, Nadia Saoudi, Elena Elez Fernandez, Pilar Navarro, Josep Tabernero, Roger R Gomis, Eduard Batlle, Jorge Pisonero, Andres Cervantes, Clara Montagut, Alexandre Calon
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy. Nature communications 14 (1) (2023)
Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, Alba Recort-Bascuas, Ana Méndez, Noemí Manero-Rupérez, Daniele Lo Re, Elisa I Rivas, Marc Guiu, Melissa Zwick, Mar Iglesias, Carolina Martinez-Ciarpaglini, Noelia Tarazona, Monica Varese, Xavier Hernando-Momblona, Adrià Cañellas-Socias, Mayra Orrillo, Marta Garrido, Nadia Saoudi, Elena Elez Fernandez, Pilar Navarro, Josep Tabernero, Roger R Gomis, Eduard Batlle, Jorge Pisonero, Andres Cervantes, Clara Montagut, Alexandre Calon
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy. Nature communications 14 (1) (2023)
Elena Elez Fernandez, Javier Ros, Josep Tabernero
Seeking therapeutic synergy in BRAF mutant colorectal cancer. Nature medicine 29 (2) (2023)
Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol, Alba Recort-Bascuas, Ana Méndez, Noemí Manero-Rupérez, Daniele Lo Re, Elisa I Rivas, Marc Guiu, Melissa Zwick, Mar Iglesias, Carolina Martinez-Ciarpaglini, Noelia Tarazona, Monica Varese, Xavier Hernando-Momblona, Adrià Cañellas-Socias, Mayra Orrillo, Marta Garrido, Nadia Saoudi, Elena Elez Fernandez, Pilar Navarro, Josep Tabernero, Roger R Gomis, Eduard Batlle, Jorge Pisonero, Andres Cervantes, Clara Montagut, Alexandre Calon
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy. Nature communications 14 (1) (2023)
Javier Ros, Francesc Salva, Cristina Dopazo, Daniel López, Nadia Saoudi, Iosune Baraibar, Ramon Charco, Josep Tabernero, Elena Elez Fernandez
Liver transplantation in metastatic colorectal cancer: are we ready for it? British journal of cancer (2023)
Eric Van Cutsem, Rona Yaeger, Jean-Pierre Delord, Josep Tabernero, Lillian L Siu, Michel Ducreux, Salvatore Siena, Elena Elez Fernandez, Stefan Kasper, Thomas Zander, Neeltje Steeghs, Danielle Murphy, Michelle Edwards, Zev A Wainberg
Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal Cancer. The oncologist (2023)
Elena Elez Fernandez, Javier Ros, Josep Tabernero
Seeking therapeutic synergy in BRAF mutant colorectal cancer. Nature medicine (2023)
Elena Elez Fernandez, Javier Ros, Josep Tabernero
Seeking therapeutic synergy in BRAF mutant colorectal cancer. Nature medicine 29 (2) (2023)
Vivek Subbiah, Robert J Kreitman, Zev A Wainberg, Anas Gazzah, Ulrik N Lassen, Alexander Stein, Patrick Y Wen, Sascha Dietrich, Maja J A de Jonge, Jean Yves Blay, Antoine Italiano, Kan Yonemori, Daniel C Cho, Filip Yves Francine De Vos, Philippe Moreau, Elena Elez Fernandez, Jan H M Schellens, Christoph C Zielinski, Suman Redhu, Aislyn Boran, Vanessa Q Passos, Palanichamy Ilankumaran, Yung-Jue Bang
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial. Nature medicine (2023)
Joana Vidal, Maria Concepción Fernández-Rodríguez, David Casadevall, Pilar García Alfonso, David Páez, Marta Guix, Vicente Alonso, María Teresa Cano, Cristina Santos, Gema Durán, Elena Elez Fernandez, Jose Luis Manzano, Rocio Garcia-Carbonero, María Reyes Ferreiro, Ferran Losa, Estela Pineda Losada, Javier Sastre, Fernando Rivera, Beatriz Bellosillo, Josep Tabernero, Enrique Aranda, Ramón Salazar, Clara Montagut
Liquid biopsy detects early molecular response and predicts benefit to first-line chemotherapy plus cetuximab in metastatic colorectal cancer: PLATFORM-B study. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Elena Elez Fernandez, Javier Ros, Jose Fernández, Guillermo Villacampa, Ana Belén Moreno-Cárdenas, Carlota Arenillas, Kinga Bernatowicz, Raquel Comas, Shanshan Li, David Philip Kodack, Roberta Fasani, Ariadna Garcia, Javier Gonzalo-Ruiz, Alejandro Piris-Gimenez, Paolo G Nuciforo, Grainne Kerr, Rossana Intini, Aldo Montagna, Marco Maria Germani, Giovanni Randon, Ana Vivancos, Ron Smits, Diana Graus, Raquel Perez-Lopez, Chiara Cremolini, Sara Lonardi, Filippo Pietrantonio, Rodrigo Dienstmann, Josep Tabernero, Rodrigo A Toledo
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF<sup>V600E</sup> metastatic colorectal cancer. Nature medicine 28 (10) (2022)
Elena Elez Fernandez, T Quintanar, J Bosch-Barrera, J Corral, N Lainez, V Moreno, C A Rodriguez, E Gonzalez-Flores, A Cervantes
The Medical Oncology resident mentor: situation and workload. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 21 (3) (2018)

Elena Elez Fernandez.css-eqlu8i{font-size:small;padding-left:4px;} (Elena Elez, E Elez, Elena Élez)

Publication Activity (10 Years)

Top Topics

Top Venues

Elena Elez Fernandez (Elena Elez, E Elez, Elena Élez)